MTOR and neoplasm with perivascular epithelioid cell differentiation: Recent studies have highlighted the role of TSC1/TSC2 gene mutations and mTOR pathway activation in PEComas, which not only contribute to tumorigenesis but also provide potential therapeutic targets.